Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Claire Riley

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
Neurology(R) Neuroimmunology & Neuroinflammation|February 10, 2025
Progressive Myelitis in a 63-Year-Old Woman: A Case Report From the National Multiple Sclerosis Society Case Conference ProceedingsKimberly A DiMauro, Morgan E Heber, Jonathan Lee, et al.
Multiple Sclerosis and Related Disorders|July 5, 2022
The impact of socioeconomic status on subsequent neurological outcomes in multiple sclerosisDevi Sai Sri Kavya Boorgu, Shruthi Venkatesh, Chirag M Lakhani, et al.
Multiple Sclerosis and Related Disorders|February 5, 2022
Hypogonadism in men with multiple sclerosis: Prevalence and clinical associationsClaudiu Diaconu, Annie J Lee, Kaho Onomichi, et al.
International Journal of MS Care|March 7, 2018
Pregnancy Outcomes from the Branded Glatiramer Acetate Pregnancy DatabaseMagnhild Sandberg-Wollheim, Orit Neudorfer, Augusto Grinspan, et al.
Multiple Sclerosis and Related Disorders|September 3, 2021
Myelin oligodendrocyte glycoprotein (MOG) antibody-mediated disease: The difficulty of predicting relapsesSamantha E Epstein, Seth Levin, Kaho Onomichi, et al.
Multiple Sclerosis and Related Disorders|January 11, 2022
Worsening physical functioning in patients with neuroinflammatory disease during the COVID-19 pandemicElle Levit, Inessa Cohen, Megan Dahl, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|August 30, 2022
Toward Precision Phenotyping of Multiple SclerosisDavid Pitt, Chih Hung Lo, Susan A Gauthier, et al.
Neurology|January 23, 2024
Disparities by Race in Pregnancy Care and Clinical Outcomes in Women With Multiple Sclerosis: A Diverse Multicenter CohortAnne Marie Radzik, Lilyana Amezcua, Annika Anderson, et al.
Contemporary Clinical Trials|October 24, 2025
The TRaditional versus Early Aggressive Therapy for Multiple Sclerosis (TREAT-MS) trial: design and baseline characteristics of participantsEllen M Mowry, Peiqing Qian, William Meador, et al.
Contemporary Clinical Trials|August 14, 2016
Design, rationale, and baseline characteristics of the randomized double-blind phase II clinical trial of ibudilast in progressive multiple sclerosisRobert J Fox, Christopher S Coffey, Merit E Cudkowicz, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
Neurology(R) Neuroimmunology & Neuroinflammation|February 10, 2025
Progressive Myelitis in a 63-Year-Old Woman: A Case Report From the National Multiple Sclerosis Society Case Conference ProceedingsKimberly A DiMauro, Morgan E Heber, Jonathan Lee, et al.
Multiple Sclerosis and Related Disorders|July 5, 2022
The impact of socioeconomic status on subsequent neurological outcomes in multiple sclerosisDevi Sai Sri Kavya Boorgu, Shruthi Venkatesh, Chirag M Lakhani, et al.
Multiple Sclerosis and Related Disorders|February 5, 2022
Hypogonadism in men with multiple sclerosis: Prevalence and clinical associationsClaudiu Diaconu, Annie J Lee, Kaho Onomichi, et al.
International Journal of MS Care|March 7, 2018
Pregnancy Outcomes from the Branded Glatiramer Acetate Pregnancy DatabaseMagnhild Sandberg-Wollheim, Orit Neudorfer, Augusto Grinspan, et al.
Multiple Sclerosis and Related Disorders|September 3, 2021
Myelin oligodendrocyte glycoprotein (MOG) antibody-mediated disease: The difficulty of predicting relapsesSamantha E Epstein, Seth Levin, Kaho Onomichi, et al.
Multiple Sclerosis and Related Disorders|January 11, 2022
Worsening physical functioning in patients with neuroinflammatory disease during the COVID-19 pandemicElle Levit, Inessa Cohen, Megan Dahl, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|August 30, 2022
Toward Precision Phenotyping of Multiple SclerosisDavid Pitt, Chih Hung Lo, Susan A Gauthier, et al.
Neurology|January 23, 2024
Disparities by Race in Pregnancy Care and Clinical Outcomes in Women With Multiple Sclerosis: A Diverse Multicenter CohortAnne Marie Radzik, Lilyana Amezcua, Annika Anderson, et al.
Contemporary Clinical Trials|October 24, 2025
The TRaditional versus Early Aggressive Therapy for Multiple Sclerosis (TREAT-MS) trial: design and baseline characteristics of participantsEllen M Mowry, Peiqing Qian, William Meador, et al.
Contemporary Clinical Trials|August 14, 2016
Design, rationale, and baseline characteristics of the randomized double-blind phase II clinical trial of ibudilast in progressive multiple sclerosisRobert J Fox, Christopher S Coffey, Merit E Cudkowicz, et al.
Pageof 4